Onward Assist is an Oncology AI platform for better treatment decisions.
Onward Assist is an advanced cancer prognostics platform helping Oncologists take better treatment decisions and hence improve outcomes. Onward provides computer vision and ML-based automated diagnostics tools and treatment decision support tools used by Histopathologists, Radiologists, Oncologists. The PathAssist product combines (a) the AI layer with machine learning and computer vision-based tools for automated diagnostics in histopathology, with (b) Pathology workflow/ Telepathology solution as well as (c) a low-cost slide digitisation hardware.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 16, 2020 | Seed | — | 1 | India EdisonTM Accelerator | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
India EdisonTM Accelerator | Yes | Seed |